TITLE
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer

ORGANISM
Homo sapiens

SUMMARY
This SuperSeries is composed of the SubSeries listed below.

DESIGN
Refer to individual Series

